Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Department of Surgery, Yang Hospital, Seoul, Korea.
Gut Liver. 2021 Sep 15;15(5):742-751. doi: 10.5009/gnl20289.
BACKGROUND/AIMS: We aimed to evaluate the clinical characteristics and long-term prognosis of elderly-onset ulcerative colitis (EOUC) in Korean patients over a 30-year period using a wellestablished population-based cohort in the Songpa-Kangdong district of Seoul, Korea.
Clinical characteristics and prognosis were compared between two groups: EOUC, defined as UC diagnosed in individuals aged ≥60 years and non-EOUC (N-EOUC), defined as UC diagnosed in individuals aged 18 to 59 years.
We identified 99 patients with EOUC (10.3%) and 866 patients with N-EOUC (89.7%) between 1986 and 2015. During the median follow-up of 104.5 months, the overall exposure to medications was comparable between patients with EOUC and N-EOUC (p=0.091 for corticosteroids, p=0.794 for thiopurines, and p=0.095 for anti-tumor necrosis factor agents). The cumulative risks of disease outcomes were also comparable between patients with EOUC and N-EOUC (22.4% vs 30.4% for proximal disease extension [p=0.351], 11.9% vs 18.1% for hospitalization [p=0.240], and 2.3% vs 1.8% for colectomy [p=0.977]) at 10 years after diagnosis. Multivariate Cox regression analysis revealed that corticosteroid use at diagnosis was an independent predictor of proximal disease extension (hazard ratio [HR], 6.216; 95% confidence interval [CI], 1.314 to 28.826) and hospitalization (HR, 11.241; 95% CI, 3.027 to 41.742) in patients with EOUC.
In this population-based study from Korea, the pattern of medication use seemed comparable between the EOUC and N-EOUC groups. Moreover, patients with EOUC and those with N-EOUC have a similar disease course in terms of proximal disease extension, hospitalization, and colectomy.
背景/目的:我们旨在通过韩国首尔松坡-姜东区一个经过良好建立的人群队列,评估 30 年来韩国老年发病溃疡性结肠炎(EOUC)的临床特征和长期预后。
比较两组患者的临床特征和预后:EOUC 定义为年龄≥60 岁诊断的溃疡性结肠炎,非 EOUC(N-EOUC)定义为年龄 18 至 59 岁诊断的溃疡性结肠炎。
我们在 1986 年至 2015 年期间发现 99 例 EOUC(10.3%)和 866 例 N-EOUC(89.7%)患者。在中位随访 104.5 个月期间,EOUC 患者和 N-EOUC 患者总体药物暴露情况相似(皮质类固醇 p=0.091,硫嘌呤 p=0.794,抗肿瘤坏死因子药物 p=0.095)。EOUC 患者和 N-EOUC 患者疾病结局的累积风险也相似(近端疾病扩展 22.4% vs 30.4% [p=0.351],住院 11.9% vs 18.1% [p=0.240],结肠切除术 2.3% vs 1.8% [p=0.977])诊断后 10 年。多变量 Cox 回归分析显示,诊断时使用皮质类固醇是 EOUC 患者近端疾病扩展(危险比 [HR],6.216;95%置信区间 [CI],1.314 至 28.826)和住院(HR,11.241;95% CI,3.027 至 41.742)的独立预测因素。
在这项来自韩国的基于人群的研究中,EOUC 和 N-EOUC 两组患者的药物使用模式似乎相似。此外,EOUC 患者和 N-EOUC 患者在近端疾病扩展、住院和结肠切除术方面具有相似的疾病进程。